Infliximab Indications & Contraindications: Acute Sinusitis Is NOT an Indication

FDA-Approved Indications for Infliximab (Remicade®)

  • Rheumatoid Arthritis (with methotrexate)
  • Crohn's Disease (moderate-severe, fistulizing)
  • Ulcerative Colitis (moderate-severe)
  • Ankylosing Spondylitis
  • Psoriatic Arthritis
  • Plaque Psoriasis (chronic severe)
  • Pediatric Crohn's / UC (age ≥6)

Question Analysis

The question lists four options; Acute Sinusitis (D) is NOT an indication.

Mechanism

Infliximab = chimeric monoclonal antibody against TNF-α. Blocks soluble & transmembrane TNF-α → reduces inflammatory cascade in autoimmune diseases.

Key Safety Considerations

  • TB screening (latent TB activation risk)
  • Hepatitis B reactivation
  • Infection risk (opportunistic, bacterial, fungal)
  • Malignancy risk (lymphoma, skin cancer)
  • Heart failure exacerbation
  • Demyelinating disorders
  • Pregnancy category B (crosses placenta 2nd/3rd tri)

Administration

  • IV infusion over 2+ hours
  • Premedication (antihistamine, acetaminophen, ± steroid)
  • Dosing: weight-based, condition-specific intervals

Illness - Related Articles